(2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid; cis-4-hydroxyproline; (4S)-4-hydroxy-L-proline; L-Proline, 4-hydroxy-, (4S)-; L-Hydroxyproline; allo-4-Hydroxy-L-proline; L-cis-4-hydroxyproline; L-Allohydroxyproline; UNII-43V78B6A3B; L-allo-hydroxyproline; cis-Hydroxyproline; 4-cis-L-hydroxyproline; Cis -4-hydroxy-L-proline; 4-hydroxyproline; CHEMBL1233477; 43V78B6A3B; allo-4-Hydroxyproline; MFCD00064319; L-Proline, allo-hydroxy-; Hydroxy-L-Proline [Allo]; (2S,4S)-4-hydroxy-2-pyrrolidinecarboxylic acid; NSC 206274; Hydroxyproline cis-form; cis -4-Hydroxy-D-proline; MFCD00064320; EINECS 210-542-1; cis-L-hydroxyproline; (4s)-hydroxyproline; zlchem 1205; PubChem10982; PubChem12571; SCHEMBL19307; CTK3J1665; DTXSID20883473; ZLD0674; ZINC901736; ACN-S002988; ACT02235; ANW-33952; BDBM50357209; KM0546; AKOS016015787; AC-2250; AC-3101; CS-W009077; MB00510; KS-00000K44; L-Proline, 4-hydroxy-, cis- (9CI); Proline, 4-allo-hydroxy-, L- (8CI); AM808165; AS-15085; cis-4-Hydroxypyrrolidine-2-carboxylic acid; C01015; 618H279; Q-200862; (2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid HCl; cis-4-Hydroxy-L-proline, collagen synthesis inhibitor; Q27103674; cis-4-Hydroxy-L-proline, Vetec(TM) reagent grade, 98%; F8880-8952; (2S,4S)-(-)-4-HYDROXY-2-PYRROLINECARBOXYLIC ACID; (2S,4S)-(-)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; Cis-4-Hydroxy-L-proline(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic Acid